Scilex Holding Co

Scilex Holding Company, listed under ticker VCKA, is a post-merger SPAC entity that originated as Vickers Vantage Corp. I, sponsored by Vickers Vantage Sponsor I LLC. The blank-check vehicle completed its initial public offering in 2021, targeting the healthcare and biopharmaceutical sector, before combining with Scilex Holding Company, a commercial-stage pharmaceutical firm concentrated on non-opioid pain management therapies. The company filed an 8-K current report with the SEC on September 26, 2025, under accession number 0001193125-25-220481, continuing its post-combination disclosure obligations. For full filing histories, deal timelines, and SPAC market analytics on Scilex Holding Company and hundreds of other transactions, sign up for a free account at SpacDesk.